Advertisement

Advertisement
Arthritis
MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint Print E-mail
User Rating: / 0
Wednesday, 26 November 2008
Pharmaceutical News MorphoSys AG and Galapagos NV announced today the launch of a long term co-development alliance aimed at discovering and developing antibody therapies based on novel modes of action in bone and joint disease, including rheumatoid arthritis, osteoporosis and osteoarthritis.
Read more...
 
Rheumatoid arthritis drugs too slow to stop damage Print E-mail
User Rating: / 0
Tuesday, 11 November 2008
Drug Trials A study by New Zealand researchers has questioned the recent treatment approaches for rheumatoid arthritis and say they may be too slow in controlling the start of the joint damage the disease causes.
Read more...
 
Scientists on a quest to find the right prescription for exercise Print E-mail
User Rating: / 0
Sunday, 09 November 2008
Medical Research News Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.
Read more...
 
We all know physical activity is good for you. But why exactly is it good for you? Print E-mail
User Rating: / 0
Saturday, 08 November 2008
Medical Research News What effect does exercise have on the cells and tissues of the body? What do we need to know so that we can use physical activity more effectively to combat chronic diseases like arthritis, diabetes and heart disease?
Read more...
 
Pycnodysostosis sheds light on enzyme's role in bone metabolism Print E-mail
User Rating: / 0
Wednesday, 05 November 2008
Medical Condition News Pycnodysostosis, a condition from which the painter Henri de Toulouse-Lautrec suffered, is a genetic disease characterized by short stature.This infrequent disease, surprisingly, provides a window into how joints are destroyed by arthritis.
Read more...
 
Wide variability in rheumatoid arthritis drug Methotrexate suggests alternative dosing should be con Print E-mail
User Rating: / 0
Wednesday, 05 November 2008
Drug Trials Methotrexate (MTX) is usually used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.Despite its widespread use, the understanding of its mechanism of action and pharmacokinetics is limited.
Read more...
 
Canadian study to look at exercise and physical activity Print E-mail
User Rating: / 0
Wednesday, 05 November 2008
Medical Research News We all know physical activity is great for you. But why accurately is it great for you? What effect does exercise have on the cells and tissues of the body?
Read more...
 
Pre-treatment MRI eliminates unnecessary surgery for children with suspected musculosketal infection Print E-mail
User Rating: / 0
Tuesday, 04 November 2008
Medical Procedure News Pre-treatment MRI can eliminate unnecessary diagnostic or surgical procedures for children with suspected musculoskeletal infections (septic arthritis and osteomyelitis) according to a study performed at Vanderbilt Children's Hospital in Nashville, TN.
Read more...
 
Symptoms of fibromyalgia related to dysfunction in parts of brain where pain is processed Print E-mail
User Rating: / 0
Tuesday, 04 November 2008
Medical Condition News Using single photon release computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the thought that symptoms of the disorder are related to a...
Read more...
 
FDA accepts Arana's anti-inflammatory IND Print E-mail
User Rating: / 0
Monday, 03 November 2008
Pharmaceutical News Biotechnology company Arana Therapeutics Limited today announced that lead anti-inflammatory compound, ART621 has successfully passed review of its rheumatoid arthritis Investigational New Drug (IND) application by the US Food and Drug Administration (FDA).
Read more...
 
Gender differences in experience of rheumatism Print E-mail
User Rating: / 0
Monday, 15 September 2008
Medical Condition News Rheumatoid arthritis is frequently a more painful experience for women than it is for men, even though the visible symptoms are the same. Scientists are now saying that doctors should take more account of these subjective differences when assessing the need for medication.
Read more...
 
FDA forces manufacturers of TNF-blockers to highlight risk of fungal infections Print E-mail
User Rating: / 0
Friday, 05 September 2008
Read more...
 
Knee osteoarthritis a growing problem in U.S. Print E-mail
User Rating: / 0
Wednesday, 03 September 2008
Medical Condition News Almost half of all U.S. adults and almost two-thirds of obese adults will develop painful osteoarthritis of the knee by age 85, a study based at the University of North Carolina at Chapel Hill suggests.
Read more...
 
Researchers discover key details of how rheumatoid arthritis destroys bone Print E-mail
User Rating: / 0
Monday, 25 August 2008
Medical Research News Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry.
Read more...
 
New discovery on how rheumatoid arthritis destroys bone Print E-mail
User Rating: / 0
Thursday, 21 August 2008
Medical Research News Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry.
Read more...
 
New treatment in the pipeline for leukaemia and rheumatoid arthritis Print E-mail
User Rating: / 0
Monday, 11 August 2008
Medical Research News Australian scientists believe they are well on the way to developing a new treatment for leukaemia and inflammatory diseases like rheumatoid arthritis and asthma.
Read more...
 
Retirement could be hazardous for the health Print E-mail
User Rating: / 0
Wednesday, 30 July 2008
Medical Studies/Trials According to the Australian Bureau of Statistics (ABS), retirement could be hazardous for the health. The ABS says older workers have lower rates of heart disease, diabetes, fatness and arthritis than their peers who are retired.
Read more...
 
Rheumatoid arthritis doubles a person's risk of heart attack Print E-mail
User Rating: / 0
Wednesday, 30 July 2008
Medical Condition News People coping with rheumatoid arthritis or lupus already have a lot to deal with. Even so, paying attention to heart health may be particularly essential for this group.
Read more...
 
Frankincense reduces the symptoms of osteoarthritis Print E-mail
User Rating: / 0
Wednesday, 30 July 2008
Medical Research News An enriched extract of the 'Indian Frankincense' herb Boswellia serrata has been proven to decrease the symptoms of osteoarthritis.
Read more...
 
Defining healthcare needs for chronic illness Print E-mail
User Rating: / 0
Tuesday, 22 July 2008
Medical Studies/Trials A research paper in the newest issue of Medical Journal of Australia has provided the first insight into the prevalence and patterns of multimorbidity in Australia.
Read more...
 
Could arthritis wonder drugs provide clues for all disease? Print E-mail
User Rating: / 0
Friday, 18 July 2008
Medical Research News Drugs that have helped treat millions of rheumatoid arthritis sufferers may hold the key to many more medical conditions, including atherosclerosis - a leading cause of heart disease - says the researcher who jointly invented and developed them.
Read more...
 
Foot orthoses reduce foot pain caused by arthritis Print E-mail
User Rating: / 0
Thursday, 17 July 2008
Devices/Technology Custom-made insoles known as foot orthoses can decrease foot pain caused by arthritis, overly prominent big toe joints and very arched feet, a new systematic review shows.
Read more...
 
GILZ protein may have big role in making more bone and less fat Print E-mail
User Rating: / 0
Wednesday, 02 July 2008
Medical Research News A little protein may have a big role in helping you make more bone and less fat, researchers say.
Read more...
 
Being born over 10 pounds increases risk of developing rheumatoid arthritis Print E-mail
User Rating: / 0
Monday, 30 June 2008
Medical Studies/Trials People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of...
Read more...
 
Rheumatoid Arthritis Treatment Guidelines Updated Print E-mail
User Rating: / 0
Thursday, 26 June 2008
THURSDAY, June 26 New recommendations for the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) have been developed by the American College of Rheumatology.
Read more...
 
Rheumatoid Arthritis Drug Boosts Melanoma Incidence Print E-mail
User Rating: / 0
Saturday, 21 June 2008
FRIDAY, June 20 Rheumatoid arthritis (RA) patients treated with methotrexate have an increased incidence of melanoma and other cancers, an Australian study says. Methotrexate (MTX) is a disease-modifying anti-rheumatic drug (DMARD) normally prescribed to RA patients.
Read more...
 
Biological medicine helps more people with rheumatoid arthritis Print E-mail
User Rating: / 0
Monday, 16 June 2008
Medical Condition News Patients who have lately developed rheumatoid arthritis respond better to treatment with biological medicine in combination with conventional pharmacological medicine.
Read more...
 
Golimumab Eases Rheumatoid Arthritis Symptoms Print E-mail
User Rating: / 0
Wednesday, 11 June 2008
WEDNESDAY, June 11 Adding monthly injections of golimumab to weekly doses of methotrexate helped most people with rheumatoid arthritis, even putting some into remission, 2 new studies show.
Read more...
 
High prevalence of periodontal disease in rheumatoid arthritis found Print E-mail
User Rating: / 0
Wednesday, 11 June 2008
Medical Condition News Over 1.3 million Americans suffer from rheumatoid arthritis (RA), a chronic, inflammatory disease of the joints. RA is a disabling condition, and can lead to long-term joint damage resulting in persistent pain and loss of function in affected areas.
Read more...
 
Drinking Cuts Rheumatoid Arthritis Risk Print E-mail
User Rating: / 0
Thursday, 05 June 2008
THURSDAY, June 5 People who drink alcohol regularly may cut their risk of developing rheumatoid arthritis, a new study finds.
Read more...
 
<< Start < Prev 1 2 3 Next > End >>

Results 1 - 30 of 69
Latest news in this category:

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint
Wednesday, 26 November 2008
Pharmaceutical News MorphoSys AG and Galapagos NV announced today the launch of a long term co-development alliance aimed at discovering and developing antibody therapies based on novel modes of action in bone and joint disease, including rheumatoid arthritis, osteoporosis and osteoarthritis.

Rheumatoid arthritis drugs too slow to stop damage
Tuesday, 11 November 2008
Drug Trials A study by New Zealand researchers has questioned the recent treatment approaches for rheumatoid arthritis and say they may be too slow in controlling the start of the joint damage the disease causes.

Scientists on a quest to find the right prescription for exercise
Sunday, 09 November 2008
Medical Research News Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.

We all know physical activity is good for you. But why exactly is it good for you?
Saturday, 08 November 2008
Medical Research News What effect does exercise have on the cells and tissues of the body? What do we need to know so that we can use physical activity more effectively to combat chronic diseases like arthritis, diabetes and heart disease?

Pycnodysostosis sheds light on enzyme's role in bone metabolism
Wednesday, 05 November 2008
Medical Condition News Pycnodysostosis, a condition from which the painter Henri de Toulouse-Lautrec suffered, is a genetic disease characterized by short stature.This infrequent disease, surprisingly, provides a window into how joints are destroyed by arthritis.

Wide variability in rheumatoid arthritis drug Methotrexate suggests alternative dosing should be con
Wednesday, 05 November 2008
Drug Trials Methotrexate (MTX) is usually used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.Despite its widespread use, the understanding of its mechanism of action and pharmacokinetics is limited.

Canadian study to look at exercise and physical activity
Wednesday, 05 November 2008
Medical Research News We all know physical activity is great for you. But why accurately is it great for you? What effect does exercise have on the cells and tissues of the body?
Latest News